Post by ABX-CRO advanced pharmaceutical services Forschungsgesellschaft

SNMMI 2026 is an outstanding opportunity for our team to engage with researchers, clinicians, and industry leaders driving innovation in #NuclearMedicine and #MolecularImaging. The scientific discussions around radiopharmaceutical development, #Theranostics, and next-generation imaging technologies highlight the tremendous momentum within the field and the growing potential of precision medicine to improve patient outcomes. We are excited to be part of these conversations and to explore new collaborations, partnerships, and business opportunities. Our European and US clinical operations team, along with our management and business development teams, are on-site throughout the meeting and welcome the opportunity to connect with professionals interested in discussing scientific advancements, strategic partnerships, and future developments in the field. Feel free to stop by our booth #1662 — we look forward to meeting you and continuing the conversation. #SNMMI2026 #Radiopharmaceuticals